About: covid:arg/1b1a69877d0ed38e1c3573e8535e8667ed58c9f3/1   Goto Sponge  NotDistinct  Permalink

An Entity of Type : amo:Evidence, within Data Space : wasabi.inria.fr associated with source document(s)

AttributesValues
type
wasQuotedFrom
sioca:supports
aif:formDescription
  • Novaferon inhibited the viral replication ( EC50 = 1 . 02 ng / ml ) , and prevented viral infection ( EC50 = 0 . 10 ng / ml ) . Results from the 89 enrolled COVID - 19 patients showed that both Novaferon and Novaferon plus Lopinavir / Ritonavir groups had significantly higher viral clearance rates on day 6than Lopinavir
proves
is hasSource of
is sioca:supports of
is has evidence of
is proves of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software